Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

About this update from Vivani Medical, Inc.

ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of August Moretti to its board of directors. Concurrent with this appointment, the Company announced the retirement of Dr. Dean Baker from the board. "We are pleased to welcome August Moretti to our board at this transformative stage for Vivani," said Gregg Williams, Chairman of the Board. "His expertise will be instrumental as we advance our lead semaglutide implant, NPM-139, through clinical-stage development and continue to leverage our proprietary NanoPortal™ technology to address chronic diseases." Mr. Moretti joins the board with extensive operating and financial executive experience spanning all phases of company growth, from early-stage development to product commercialization. He will serve as the chair of the Audit Committee and member of the Compensation Committee. Mr. Moretti most recently served as the Chief Financial Officer of 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT) from 2019 until his retirement in September 2023. Previously, he was the CFO of Assertio Therapeutics from 2012 to 2018 and held CFO and General Counsel roles at Alexza Pharmaceuticals, Inc., which was publicly held until its acquisition by Ferrer Pharmaceuticals, and Alavita, Inc. Earlier in his career, Mr. Moretti was a partner at Heller Erhman, where he represented life science companies in mergers, acquisitions, and public financings. He currently serves as a member of the Board and chair of the Audit Committee for Cibus, Inc. Mr. Moretti holds a B.A. in Economics from Princeton University and a J.D. from Harvard Law School. Dr. Dean Baker retires after a distinguished tenure on the board, during which he also served as chair of the Audit Committee, chair of the Compensation Committee and member of the Corporate Governance Committee. Dr. Baker provided critical guidance during the merger of Nano Precision Medical and Second Sight Medical Products. Dr. Baker's career includes senior leadership roles at Northrop Grumman, Advanced Bionics, and the Alfred E. Mann Institute at USC. "On behalf of the entire board, I want to thank Dean for his dedicated service and invaluable contributions to Vivani," added Mr. Williams.&nb...

View stock analysis, news, and events for Vivani Medical, Inc.